(Q73870904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Antioxidant agents in the treatment of Graves' ophthalmopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

E A Bouzas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Karadimas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Mastorakos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D A Koutras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Ophthalmology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

618-622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

Thyroid-associated eye disease: clinical management

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Pathogenesis of Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

The treatment of Graves' ophthalmopathy in an incidence cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Thyroid-associated eye disease: pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Modulation of fibroblast proliferation by oxygen free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Diagnostic criteria for Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Uniocular fields of fixation in thyroid eye disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Prevalence, natural history and surgical treatment of exophthalmos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Natural history of thyroid associated ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Association between Graves' ophthalmopathy and smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Oxygen radicals and human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900359-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(00)00359-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844053%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference